FTRE

What one share of Fortrea Holdings holds

Services – Medical Laboratories

Fortrea Holdings Inc. is a leading global contract research organization (“CRO”), providing biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology and medical device customers.

Fortrea Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Sales$28.74
Profit−$0.92
Capex (buildings and equipment)$0.34
Free cash flow$2.10
Cash and investments$1.77
Debt$11.09
Book value$5.51

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2021$34.43$1.10$0.30$1.61—$36.73
2022$31.95$2.10$0.61$0.32—$37.61
2023$32.01−$0.28$0.45$1.44—$19.30
2024$30.13−$3.67$0.28$2.65—$15.19
2025$29.85−$10.81$0.28$0.97—$6.05

Common questions about Fortrea Holdings

How much does one share of Fortrea Holdings earn?

Over the last 12 months, Fortrea Holdings lost $0.92 for each share on $28.74 of sales.

Does Fortrea Holdings pay a dividend?

Fortrea Holdings didn’t pay a dividend over the last 12 months, according to its SEC filings.

What is Fortrea Holdings’s book value per share?

Fortrea Holdings’s book value is $5.51 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.

How much cash and debt does each share of Fortrea Holdings have?

Each share of Fortrea Holdings has $1.77 of cash and investments and $11.09 of debt, as of June 30, 2026.

What is Fortrea Holdings’s free cash flow per share?

$2.10 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.